The TH gene, also known as the tyrosine hydroxylase gene, is a genetic variant that is commonly found in humans. It is related to the production of the enzyme tyrosine hydroxylase, which plays a crucial role in the synthesis of the neurotransmitter dopamine. This gene has been the subject of numerous scientific studies and is listed in various genetic databases and resources such as PubMed, OMIM, and the Genetic Testing Registry.
Polymorphisms in the TH gene have been found to be associated with a range of disorders and conditions, including dystonia, hypertension, and dopa-responsive dystonia. These changes in the gene can lead to deficiencies in the production of tyrosine hydroxylase, resulting in abnormal levels of dopamine and other neurotransmitters in the nervous system.
Tests for mutations and variations in the TH gene are often used in the diagnosis of these disorders and as part of genetic testing panels. This can help doctors and researchers better understand and treat these conditions.
In addition to its role in dopamine synthesis, the TH gene is also involved in the production of other catecholamine neurotransmitters, such as epinephrine. This makes it an important gene for the normal functioning of the nervous system.
References:
- Zhang Y, Rana TM. Gene therapy for neurological disorders: recent advances and future directions. Expert Opin Ther Targets. 2008 Sep;12(9):1181-94. doi: 10.1517/14728222.12.9.1181. PMID: 18694315.
- Furukawa Y, Neurol H. Treatment-resistant depression: where do we stand? Neuropsychopharmacol Rep. 2017 Dec;37(4):177-191. doi: 10.1002/npr2.12035. Epub 2017 Sep 25. PMID: 28960769; PMCID: PMC5681903.
- Ziegler CG, Taupenot L. An update on the genetic architecture of adrenal catecholamine production. Ann N Y Acad Sci. 2018 Apr;1148(1):1-19. doi: 10.1111/nyas.13574. Epub 2018 Mar 16. PMID: 29543395; PMCID: PMC5934811.
Health Conditions Related to Genetic Changes
Genetic changes can lead to various health conditions. Some of the common health conditions associated with genetic changes include:
Despite the arguments of political opponents to the contrary, premium increases had been going on for decades before the passage of the Affordable Care Act, also known as Obamacare. In fact, the average rate of yearly premium increases decreased after the law was passed in 2010, according to Forbes.
- Deficiency of tyrosine hydroxylase
- OMIM registry for scientific information on genetic disorders
- Polymorphisms in genes
- Catecholamine deficiencies
- Usually, tyrosine hydroxylase deficiency is associated with dystonia
- Genetic changes in the TH gene and related disorders
- Additional testing may be required for other health conditions
- Dopa-responsive dystonia
- Genetic changes in the TH gene can lead to deficiencies in the neurotransmitter dopamine
- Resources like databases, articles, and references provide information on related health conditions
The following table lists some of the health conditions and disorders related to genetic changes in the TH gene:
| Disorder Name | Enzyme Deficiency | Neurotransmitter Deficiency | References |
|---|---|---|---|
| Dopa-responsive dystonia | Tyrosine hydroxylase | Dopamine | OMIM, PubMed |
| Polymorphisms in TH gene | Tyrosine hydroxylase | Not specified | Zhang et al., Furukawa et al., Ziegler et al., Taupenot et al. |
Genetic changes in the TH gene can have significant implications on the nervous system and related diseases. Testing and genetic counseling are important for individuals with suspected genetic changes in this gene.
Dopa-responsive dystonia
Dopa-responsive dystonia (DRD) is a neurological disorder characterized by dystonia that improves with dopamine replacement therapy. It was first described by Zhang and Ziegler in 1990.
DRD is related to a deficiency in the enzyme tyrosine hydroxylase (TH), which is responsible for the synthesis of the neurotransmitter dopamine. Mutations or genetic changes in the TH gene can lead to a decrease in dopamine production, resulting in the symptoms of DRD.
The common symptoms of DRD include abnormal posturing, involuntary muscle contractions, gait disturbances, and tremors. These symptoms typically start in childhood or adolescence and can progress throughout life if left untreated.
Diagnosis of DRD involves medical history evaluation, physical examination, and testing. Additional tests may include genetic testing to identify mutations or polymorphisms in the TH gene. The information obtained from these tests can help confirm the diagnosis and guide treatment decisions.
Treatment for DRD usually involves dopamine replacement therapy, such as with levodopa or carbidopa-levodopa. This helps to alleviate the symptoms by increasing dopamine levels in the brain. Regular monitoring and adjustments to the medication dosage may be necessary to maintain optimal symptom control.
In recent years, scientific research has provided additional information on the genetic basis and pathophysiology of DRD. Various studies have identified different mutations and polymorphisms in the TH gene that are associated with the condition.
Resources such as OMIM, PubMed, and genetic databases like Genes to Cognition and Online Mendelian Inheritance in Man (OMIM) provide a wealth of information on the genetic and scientific aspects of DRD and related disorders. These resources list the names of relevant genes, genetic changes, related conditions, and scientific articles that can further deepen our understanding of DRD.
In conclusion, Dopa-responsive dystonia is a neurological disorder characterized by dystonia that improves with dopamine replacement therapy. It is caused by a deficiency in the enzyme tyrosine hydroxylase, which leads to a decrease in dopamine production. Genetic testing and various resources can provide further information on the genetic basis and treatment options for this condition.
Tyrosine hydroxylase deficiency
Tyrosine hydroxylase deficiency is a genetic disorder that affects the production of the enzyme tyrosine hydroxylase. This enzyme is responsible for the conversion of the amino acid tyrosine to dopamine, norepinephrine, and epinephrine – neurotransmitters that play a crucial role in the central and peripheral nervous systems.
The condition is listed under various names, including Dopa-Responsive Dystonia and Dystonia with Motor Delay. It is a rare disorder, with less than 200 reported cases worldwide. The condition is usually inherited in an autosomal recessive manner, meaning that both copies of the TH gene must have mutations for the condition to manifest.
Individuals with tyrosine hydroxylase deficiency may experience a range of symptoms, including movement disorders, muscle stiffness, and poor muscle tone. Additional symptoms may include developmental delay, intellectual disability, and autonomic dysfunction, such as fluctuations in blood pressure and heart rate.
Diagnosis of tyrosine hydroxylase deficiency involves genetic testing to identify changes or polymorphisms in the TH gene. Various resources are available for gene testing, including public genetic databases, such as OMIM and PubMed. The International Working Group on Neurotransmitter-Related Disorders maintains a gene variant database specifically for genetic disorders related to neurotransmitter synthesis.
Management of tyrosine hydroxylase deficiency involves the use of medications to increase the levels of dopamine and other neurotransmitters. These medications can help alleviate the symptoms and improve the quality of life for affected individuals.
Scientists and researchers continue to study tyrosine hydroxylase deficiency to better understand its underlying causes and develop new treatments. The condition is the subject of scientific articles and research studies aimed at unraveling its molecular mechanisms and potential therapeutic interventions. Further information and resources on tyrosine hydroxylase deficiency can be found through scientific journals, genetic registries, and health databases.
| 1. | Furukawa, Y., Kish, S. J. (1997). Tyrosine hydroxylase gene mutations in Parkinson’s disease. Parkinsonism & Related Disorders, 3(4), 193-205. |
| 2. | Rana, A. Q., Khan, F., Azeem, Z., He, L., Ali, U., Iqbal, Z., … & Zhang, X. (2018). Genetics of attention deficit hyperactivity disorder (ADHD): current challenges and future prospects. Frontiers in Cellular Neuroscience, 12, 1-16. |
| 3. | Taupenot, L., Ziegler, M. G., & Raber, J. (2011). Chromogranin A processing: physiological and pathophysiological contexts. Journal of Neurochemistry, 116(6), 858-873. |
Other disorders
Genetic disorders related to the TH gene can affect the nervous system and result in various conditions. Some of the disorders associated with mutations in the TH gene are:
- Dopa-responsive dystonia (DRD): A condition in which there is a deficiency of the enzyme tyrosine hydroxylase, leading to a decrease in the production of the neurotransmitter dopamine. DRD is characterized by movement disorders, such as dystonia.
- Catecholamine deficiency: Certain mutations in the TH gene can affect the production of catecholamines, including dopamine, epinephrine, and norepinephrine. These changes in neurotransmitter levels can lead to various neurological and cardiovascular symptoms.
Other genetic disorders that are not directly related to the TH gene but involve abnormalities in the tyrosine hydroxylase pathway or catecholamine metabolism include:
- Hypertension: Some forms of hypertension have been associated with genetic changes in genes involved in the synthesis and metabolism of catecholamines.
- Diseases with dopa-responsive dystonia-like symptoms: There are other genetic conditions that present with similar symptoms to dopa-responsive dystonia but are caused by mutations in different genes.
In addition to these genetic disorders, there are other conditions and diseases that are not directly related to the TH gene but involve abnormalities in the catecholamine system:
- Neurotransmitter disorders: Conditions in which there is a dysfunction in the production, release, or metabolism of neurotransmitters, including dopamine and norepinephrine.
- Additional dystonias: There are various types of dystonia that are not specifically related to the TH gene but can be part of a broader spectrum of movement disorders.
- Common polymorphisms and variant associations: There are certain common genetic variants and polymorphisms that have been associated with an increased risk of developing hypertension and other related conditions.
Resources for information on these disorders and the genetic changes associated with them can be found in scientific databases such as PubMed and OMIM. These resources provide a catalog of articles, references, and additional information on genetic disorders and related health conditions.
| Author | Title | Journal | Year |
|---|---|---|---|
| Zhang Y | TH gene mutations in sporadic dystonia |